BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10961005)

  • 1. [5'CpG island methylation of the suppressor gene p16/CDKN2/MTS1 in renal carcinoma].
    Maestro ML; Del Barco V; Sanz-Casla MT; Moreno J; Zanna I; Redondo E; Fernández C; Resel L
    Arch Esp Urol; 2000 Jun; 53(5):417-23. PubMed ID: 10961005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene].
    Maestro de las Casas ML; Sanz-Casla MT; del Barco V; Moreno J; Zanna I; Redondo E; Fernández C; Izquierdo L; Resel Estévez L
    Arch Esp Urol; 2000 Sep; 53(7):603-9. PubMed ID: 11037653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the 5'CpG island of the FHIT gene in clear cell renal carcinomas.
    Kvasha S; Gordiyuk V; Kondratov A; Ugryn D; Zgonnyk YM; Rynditch AV; Vozianov AF
    Cancer Lett; 2008 Jul; 265(2):250-7. PubMed ID: 18378390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between methylation on SmaI locus of the CDKN2/p16 gene CpG island and lung cancer].
    Su C; Ye Y; Wang D
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):471-3. PubMed ID: 11235566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of methylation and abnormal expression of p16 gene in endometrial carcinoma].
    Yuan JR; Fu SB; Fu H; Li P
    Yi Chuan Xue Bao; 2004 May; 31(5):454-9. PubMed ID: 15478604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of inactivation of CDKN2/p16 gene by methylation and lung cancers].
    Su C; Shan X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):36-8. PubMed ID: 10653907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of methylation status of tumor suppressor gene p16 by methylation specific polymerase chain reaction].
    Zhao Y; Zhang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):333-6. PubMed ID: 10514546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
    Tang S; Luo H; Yu J; Yang D; Shu J
    Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
    Weihrauch M; Benicke M; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Br J Cancer; 2001 Apr; 84(7):982-9. PubMed ID: 11286481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inactivation of CDKN2A gene (p16) in gallbladder carcinoma].
    Roa JC; Vo Q; Araya JC; Villaseca M; Guzmán P; Ibacache GS; de Aretxabala X; Roa I
    Rev Med Chil; 2004 Nov; 132(11):1369-76. PubMed ID: 15693199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.
    Katsaros D; Cho W; Singal R; Fracchioli S; Rigault De La Longrais IA; Arisio R; Massobrio M; Smith M; Zheng W; Glass J; Yu H
    Gynecol Oncol; 2004 Sep; 94(3):685-92. PubMed ID: 15350359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.